Exact Mass: 476.2127
Exact Mass Matches: 476.2127
Found 500 metabolites which its exact mass value is equals to given mass value 476.2127
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Loperamide
Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids; Loperamide usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; Treatment should be avoided in the presence of fever or if the stool is bloody. Treatment is not recommended for patients who could suffer detrimental effects from rebound constipation. If there is a suspicion of diarrhea associated with organisms that can penetrate the intestinal walls, such as E. coli O157:H7 or salmonella, loperamide is contraindicated; Loperamide, usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; it does not affect the central nervous system like other opioids; One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally; Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines [HMDB] Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids; Loperamide usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; Treatment should be avoided in the presence of fever or if the stool is bloody. Treatment is not recommended for patients who could suffer detrimental effects from rebound constipation. If there is a suspicion of diarrhea associated with organisms that can penetrate the intestinal walls, such as E. coli O157:H7 or salmonella, loperamide is contraindicated; Loperamide, usually as hydrochloride, is a drug effective against diarrhea resulting from gastroenteritis or inflammatory bowel disease. In most countries it is available generically under brand names such as Lopex, Imodium, Dimor and Pepto Diarrhea Control; it does not affect the central nervous system like other opioids; One of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally; Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals KEIO_ID L047; [MS2] KO009036 KEIO_ID L047
2-Methoxyestrone 3-glucuronide
2-Methoxyestrone 3-glucuronide belongs to the class of organic compounds known as steroid glucuronide conjugates. These are sterol lipids containing a glucuronide moiety linked to the steroid skeleton. Thus, 2-methoxyestrone 3-glucuronide is considered to be a steroid conjugate lipid molecule. 2-Methoxyestrone 3-glucuronide is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. 2-Methoxyestrone 3-glucuronide is a natural human metabolite of 2-methoxyestrone generated in the liver by UDP glucuronosyltransferase. 2-Methoxyestrone is a metabolite of 2-hydroxyestrone (a nonuterotrophic metabolite of estradiol). Glucuronidation is used to assist in the excretion of toxic substances, drugs, or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 2-Methoxyestrone 3-glucuronide is a natural human metabolite of 2-Methoxyestrone generated in the liver by UDP glucuonyltransferase. A glucuronide conjugate of 2-methodxyestrone formed by UDP-glucuronylstransferase (UTP). 2-methoxyestrone is a metabolite of 2-hydroxyestrone (a nonuterotrophic metabolite of estradiol) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Fuscaxanthone A
2-(4-Methyl-3-pentenyl)-2-methyl-5,10-dihydroxy-9-methoxy-12-(1,1-dimethyl-2-propenyl)-2H,6H-pyrano[3,2-b]xanthene-6-one
9alpha-(2,3-epoxy-2-methylbutyryloxy)-divaricatolide-8-O-(2R,3R-epoxy-2-methylbutyrate)|9alpha-<2,3-epoxy-2-methylbutyryloxy>-divaricatolide-8-O-<2R,3R-epoxy-2-methylbutyrate>
9alpha-angeloyloxy-2alpha-hydroxy-divaricatolide-8-O-<2S,3S-epoxy-2-methylbutyrate>
(2R*,3S*,4R*,6R*,7R*,8R*,10R*,11R*,14S*)-3-angelyloxy-9-hydroxy-14-(3-hydroxy-3-methylbutanoyloxy)-14,15-epoxytrix-5(15)-en-4,12-olide
9beta-hydroxy-1beta,8beta-di-(2,3-epoxy-2-methylbutyryloxy)-6-epi-alpha-cyclocostunolide|9beta-hydroxy-1beta,8beta-di-<2,3-epoxy-2-methylbutyryloxy>-6-epi-alpha-cyclocostunolide
8beta-<5-(4,5-dihydroxytigloyloxy)-tigloyloxy>-nobilin
7,7-dimethyl-5,7-epoxypyrano[3,3:2,3]-2-(3-methyl-but-2-enyl)-dibenzo[b,f]pyrano[2,3-d]oxepin-3,7-diol|artocarpol F
(2R,3R)-2,3-dihydro-3-hydroxymethyl-7-methoxy-2-(3-methoxy-4-alpha-L-rhamnopyranosyloxyphenyl)-5-benxofuranpropanol
10alpha-hydroxy-8beta-<5-(4-hydroxytigloyl)-4-hydroxytigloyloxy>-guaia-3,11(13)-dien-12,6alpha-olide|10alpha-hydroxy-8beta-[5-(4-hydroxytigloyl)-4-hydroxytigloyloxy]-guaia-3,11(13)-dien-12,6alpha-olide
3-desacetyl-5-(4-hydroxytigloyloxy)-eupaformosanin
Val Glu Thr Glu
Asp Ser Gln Lys
Ser Glu Ile Glu
Thr Asn Asp Lys
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one
loperamide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals CONFIDENCE standard compound; INTERNAL_ID 2504 CONFIDENCE standard compound; INTERNAL_ID 8489
C26H28N4O5_1H-Imidazo[1,2-a]indole-9-propanoic acid, 2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-alpha-(4-oxo-3(4H)-quinazolinyl)-, methyl ester
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one [IIN-based: Match]
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one [IIN-based on: CCMSLIB00000845973]
1,7-bis(4-hydroxyphenyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one_major
Ala Cys Gln Arg
Ala Cys Arg Gln
Ala Met Gln Gln
Ala Gln Cys Arg
Ala Gln Met Gln
Ala Gln Gln Met
Ala Gln Arg Cys
Ala Arg Cys Gln
Ala Arg Gln Cys
Cys Ala Gln Arg
Cys Ala Arg Gln
Cys Ile Asn Gln
Cys Ile Gln Asn
Cys Leu Asn Gln
Cys Leu Gln Asn
Cys Asn Ile Gln
Cys Asn Leu Gln
Cys Asn Gln Ile
Cys Asn Gln Leu
Cys Gln Ala Arg
Cys Gln Ile Asn
Cys Gln Leu Asn
Cys Gln Asn Ile
Cys Gln Asn Leu
Cys Gln Gln Val
Cys Gln Arg Ala
Cys Gln Val Gln
Cys Arg Ala Gln
Cys Arg Gln Ala
Cys Val Gln Gln
Asp Glu Ile Thr
Asp Glu Leu Thr
Asp Glu Thr Ile
Asp Glu Thr Leu
Asp Ile Glu Thr
Asp Ile Thr Glu
Asp Lys Asn Thr
Asp Lys Gln Ser
Asp Lys Ser Gln
Asp Lys Thr Asn
Asp Leu Glu Thr
Asp Leu Thr Glu
Asp Asn Lys Thr
Asp Asn Thr Lys
Asp Gln Lys Ser
Asp Gln Ser Lys
Asp Ser Lys Gln
Asp Thr Glu Ile
Asp Thr Glu Leu
Asp Thr Ile Glu
Asp Thr Lys Asn
Asp Thr Leu Glu
Asp Thr Asn Lys
Glu Asp Ile Thr
Glu Asp Leu Thr
Glu Asp Thr Ile
Glu Asp Thr Leu
Glu Glu Ile Ser
Glu Glu Leu Ser
Glu Glu Ser Ile
Glu Glu Ser Leu
Glu Glu Thr Val
Glu Glu Val Thr
Glu Ile Asp Thr
Glu Ile Glu Ser
Glu Ile Ser Glu
Glu Ile Thr Asp
Glu Lys Asn Ser
Glu Lys Ser Asn
Glu Leu Asp Thr
Glu Leu Glu Ser
Glu Leu Ser Glu
Glu Leu Thr Asp
Glu Asn Lys Ser
Glu Asn Ser Lys
Glu Ser Glu Ile
Glu Ser Glu Leu
Glu Ser Ile Glu
Glu Ser Lys Asn
Glu Ser Leu Glu
Glu Ser Asn Lys
Glu Thr Asp Ile
Glu Thr Asp Leu
Glu Thr Glu Val
Glu Thr Ile Asp
Glu Thr Leu Asp
Glu Thr Val Glu
Glu Val Glu Thr
Glu Val Thr Glu
Gly Met Asn Arg
Gly Met Arg Asn
Gly Asn Met Arg
Gly Asn Arg Met
Gly Arg Met Asn
Gly Arg Asn Met
His His Pro Ser
His His Ser Pro
His Pro His Ser
His Pro Ser His
His Ser His Pro
His Ser Pro His
Ile Cys Asn Gln
Ile Cys Gln Asn
Ile Asp Glu Thr
Ile Asp Thr Glu
Ile Glu Asp Thr
Ile Glu Glu Ser
Ile Glu Ser Glu
Ile Glu Thr Asp
Ile Asn Cys Gln
Ile Asn Gln Cys
Ile Gln Cys Asn
Ile Gln Asn Cys
Ile Ser Glu Glu
Ile Thr Asp Glu
Ile Thr Glu Asp
Lys Asp Asn Thr
Lys Asp Gln Ser
Lys Asp Ser Gln
Lys Asp Thr Asn
Lys Glu Asn Ser
Lys Glu Ser Asn
Lys Asn Asp Thr
Lys Asn Glu Ser
Lys Asn Ser Glu
Lys Asn Thr Asp
Lys Gln Asp Ser
Lys Gln Ser Asp
Lys Ser Asp Gln
Lys Ser Glu Asn
Lys Ser Asn Glu
Lys Ser Gln Asp
Lys Thr Asp Asn
Lys Thr Asn Asp
Leu Cys Asn Gln
Leu Cys Gln Asn
Leu Asp Glu Thr
Leu Asp Thr Glu
Leu Glu Asp Thr
Leu Glu Glu Ser
Leu Glu Ser Glu
Leu Glu Thr Asp
Leu Asn Cys Gln
Leu Asn Gln Cys
Leu Gln Cys Asn
Leu Gln Asn Cys
Leu Ser Glu Glu
Leu Thr Asp Glu
Leu Thr Glu Asp
Met Ala Gln Gln
Met Gly Asn Arg
Met Gly Arg Asn
Met Met Pro Val
Met Met Val Pro
Met Asn Gly Arg
Met Asn Asn Val
Met Asn Arg Gly
Met Asn Val Asn
Met Pro Met Val
Met Pro Val Met
Met Gln Ala Gln
Met Gln Gln Ala
Met Arg Gly Asn
Met Arg Asn Gly
Met Val Met Pro
Met Val Asn Asn
Met Val Pro Met
Asn Cys Ile Gln
Asn Cys Leu Gln
Asn Cys Gln Ile
Asn Cys Gln Leu
Asn Asp Lys Thr
Asn Asp Thr Lys
Asn Glu Lys Ser
Asn Glu Ser Lys
Asn Gly Met Arg
Asn Gly Arg Met
Asn Ile Cys Gln
Asn Ile Gln Cys
Asn Lys Asp Thr
Asn Lys Glu Ser
Asn Lys Ser Glu
Asn Lys Thr Asp
Asn Leu Cys Gln
Asn Leu Gln Cys
Asn Met Gly Arg
Asn Met Asn Val
Asn Met Arg Gly
Asn Met Val Asn
Asn Asn Met Val
Asn Asn Val Met
Asn Gln Cys Ile
Asn Gln Cys Leu
Asn Gln Ile Cys
Asn Gln Leu Cys
Asn Arg Gly Met
Asn Arg Met Gly
Asn Ser Glu Lys
Asn Ser Lys Glu
Asn Thr Asp Lys
Asn Thr Lys Asp
Asn Val Met Asn
Asn Val Asn Met
Pro His His Ser
Pro His Ser His
Pro Met Met Val
Pro Met Val Met
Pro Ser His His
Pro Val Met Met
Gln Ala Cys Arg
Gln Ala Met Gln
Gln Ala Gln Met
Gln Ala Arg Cys
Gln Cys Ala Arg
Gln Cys Ile Asn
Gln Cys Leu Asn
Gln Cys Asn Ile
Gln Cys Asn Leu
Gln Cys Gln Val
Gln Cys Arg Ala
Gln Cys Val Gln
Gln Asp Lys Ser
Gln Asp Ser Lys
Gln Ile Cys Asn
Gln Ile Asn Cys
Gln Lys Asp Ser
Gln Lys Ser Asp
Gln Leu Cys Asn
Gln Leu Asn Cys
Gln Met Ala Gln
Gln Met Gln Ala
Gln Asn Cys Ile
Gln Asn Cys Leu
Gln Asn Ile Cys
Gln Asn Leu Cys
Gln Gln Ala Met
Gln Gln Cys Val
Gln Gln Met Ala
Gln Gln Thr Thr
Gln Gln Val Cys
Gln Arg Ala Cys
Gln Arg Cys Ala
Gln Ser Asp Lys
Gln Ser Lys Asp
Gln Thr Gln Thr
Gln Thr Thr Gln
Gln Val Cys Gln
Gln Val Gln Cys
Arg Ala Cys Gln
Arg Ala Gln Cys
Arg Cys Ala Gln
Arg Cys Gln Ala
Arg Gly Met Asn
Arg Gly Asn Met
Arg Met Gly Asn
Arg Met Asn Gly
Arg Asn Gly Met
Arg Asn Met Gly
Arg Gln Ala Cys
Arg Gln Cys Ala
Ser Asp Lys Gln
Ser Asp Gln Lys
Ser Glu Glu Ile
Ser Glu Glu Leu
Ser Glu Lys Asn
Ser Glu Leu Glu
Ser Glu Asn Lys
Ser His His Pro
Ser His Pro His
Ser Ile Glu Glu
Ser Lys Asp Gln
Ser Lys Glu Asn
Ser Lys Asn Glu
Ser Lys Gln Asp
Ser Leu Glu Glu
Ser Asn Glu Lys
Ser Asn Lys Glu
Ser Pro His His
Ser Gln Asp Lys
Ser Gln Lys Asp
Thr Asp Glu Ile
Thr Asp Glu Leu
Thr Asp Ile Glu
Thr Asp Lys Asn
Thr Asp Leu Glu
Thr Asp Asn Lys
Thr Glu Asp Ile
Thr Glu Asp Leu
Thr Glu Glu Val
Thr Glu Ile Asp
Thr Glu Leu Asp
Thr Glu Val Glu
Thr Ile Asp Glu
Thr Ile Glu Asp
Thr Lys Asp Asn
Thr Lys Asn Asp
Thr Leu Asp Glu
Thr Leu Glu Asp
Thr Asn Lys Asp
Thr Gln Gln Thr
Thr Val Glu Glu
Val Cys Gln Gln
Val Glu Glu Thr
Val Met Met Pro
Val Met Asn Asn
Val Met Pro Met
Val Asn Met Asn
Val Asn Asn Met
Val Pro Met Met
Val Gln Cys Gln
Val Gln Gln Cys
Val Thr Glu Glu
ST 19:4;O3;GlcA
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
3-Methyl-6-(methylpropylamino)-2-(phenylamino)fluoran
Pentanoic acid, 4-(((1,1-biphenyl)-4-ylcarbonyl)amino)-5-((2-(4-fluorophenyl)-1,1-dimethylethyl)amino)-5-oxo-, (4S)-
Flunisolide acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents
Gutolactone
A quassinoid isolated from Simaba guianensis and has been shown to exhibit antimalarial activity.
8-[[4-(Furan-2-carbonyl)piperazin-1-yl]methyl]-1,3-dimethyl-7-[(2-methylphenyl)methyl]purine-2,6-dione
4-methoxy-17-oxoestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronic acid
Norcaesalpinin D
A diterpenoid isolated from the seed kernels of Caesalpinia crista that has been found to exhibit antimalarial activity.
N-[(Z)-3-[3-(dimethylamino)propylamino]-1-[5-(3-nitrophenyl)furan-2-yl]-3-oxoprop-1-en-2-yl]-4-methylbenzamide
N-(2-adamantyl)-4-(4-ethylsulfonyl-1-piperazinyl)-3-nitrobenzamide
(1S,9R,10R,11R)-12-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-N-propyl-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
(2S)-2-[(4R,5S)-5-[[(2-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2R)-2-[(4S,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-(4-fluorophenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(2R,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2R,3R,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2R,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-N2-[2-(1-methyl-4-imidazolyl)ethyl]-6-oxo-N1-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]methanesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]methanesulfonamide
(2R)-2-[(4R,5S)-5-[[(3-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2R)-2-[(4R,5S)-5-[[(2-fluorophenyl)methyl-methylamino]methyl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-2-yl]propan-1-ol
(2S)-2-[(4R,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-(4-fluorophenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-(4-fluorophenyl)-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(2S,3R,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2R,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2S,3S,6R)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
2-[(2S,3S,6S)-3-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(4-phenylphenyl)acetamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-N2-[2-(1-methyl-4-imidazolyl)ethyl]-6-oxo-N1-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-1,2-dicarboxamide
(1R,9S,10S,11S)-12-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-N-propyl-5-pyridin-4-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
[(8R,9S,10R)-6-(2-methylphenyl)sulfonyl-9-(4-phenylphenyl)-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
2-methoxyestrone 3-O-(beta-D-glucuronide)
A steroid glucosiduronic acid that is 2-methoxyestrone having a single beta-D-glucuronic acid residue attached at position 3.
(1s,4ar,5s,6r,6as,11as,11bs)-1,6-bis(acetyloxy)-4a-hydroxy-4,4,11b-trimethyl-7-oxo-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-5-yl acetate
7-(3,7-dimethylocta-2,6-dien-1-yl)-5,9-dihydroxy-8-methoxy-2,2-dimethyl-1,11-dioxatetracen-6-one
4,5,17-trihydroxy-6,14,18-trimethyl-9,16-dioxo-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-12-yl 3-methylbut-2-enoate
(1r,4ar,6r,7s,7ar)-7-hydroxy-4,7-bis(hydroxymethyl)-6-{[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl (3s)-3-methylpentanoate
1,7-bis(4-hydroxyphenyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}heptan-3-one
(1s,4as,6s,7r,7as)-6,7-dihydroxy-4-(hydroxymethyl)-7-({[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl (3s)-3-methylpentanoate
2-(hydroxymethyl)-6-({3,11,17-trihydroxytricyclo[12.3.1.1²,⁶]nonadeca-1(18),2(19),3,5,14,16-hexaen-9-yl}oxy)oxane-3,4,5-triol
(1r,4ar,6r,7s,7ar)-7-hydroxy-4,7-bis(hydroxymethyl)-6-{[(2z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl (3s)-3-methylpentanoate
6-(2,3-dimethyloxirane-2-carbonyloxy)-5-hydroxy-5a,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-4-yl 2,3-dimethyloxirane-2-carboxylate
(1r,5r,6s,8s,9s,10s,13s,14r,15s)-8-hydroxy-5-{[(2r,3s)-3-hydroxy-2-methylbutanoyl]oxy}-10-methyl-11-oxo-4,12-dioxapentacyclo[7.7.0.0¹,⁶.0²,¹³.0¹⁰,¹⁵]hexadec-2-en-14-yl (2z)-2-methylbut-2-enoate
(3as,4s,5s,5ar,6s,7s,9as,9bs)-6,7-dihydroxy-5a,9-dimethyl-5-{[(2z)-2-methylbut-2-enoyl]oxy}-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-4-yl (2s,3s)-2,3-dimethyloxirane-2-carboxylate
(3as,4s,5s,5ar,6s,7s,9as,9bs)-6,7-dihydroxy-5a,9-dimethyl-5-{[(2z)-2-methylbut-2-enoyl]oxy}-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-4-yl (2r,3r)-2,3-dimethyloxirane-2-carboxylate
1β-hydroxyleudesma- 4, 11-dien-3-one
{"Ingredient_id": "HBIN002415","Ingredient_name": "1\u03b2-hydroxyleudesma- 4, 11-dien-3-one","Alias": "NA","Ingredient_formula": "C25H32O9","Ingredient_Smile": "CC1=CC(C(C2(C1C(C3C45C2C(C(C(=C)C4CC(=O)O3)O)(OC5)O)OC(=O)C=C(C)C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41911","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}